Last 12 months
Inside the activity.
1 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 01, 2024 Filed Jul 2, 2024 20:58 UTC |
WOLF DALE BDirector
|
GrantCommon Stock | 188 | $292.16 | $54,926.08 |
DisclosureSEC source: 0001179929-24-000114 · wk-form4_1719953916.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,191 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2024, was $292.16, which resulted in a grant of 188 shares. F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2024. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:57 UTC |
ORLANDO STEVEN JDirector
|
GrantCommon Stock | 188 | $292.16 | $54,926.08 |
DisclosureSEC source: 0001179929-24-000113 · wk-form4_1719953849.xml · nonDerivative · entry 1 ORLANDO STEVEN J · CIK 0001211493 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trust Disclosed balance after: 19,025 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2024, was $292.16, which resulted in a grant of 188 shares. F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2024. F4 · ownership.nature: Shares are held by Orlando Family Trust. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:55 UTC |
COOPERMAN DANIELDirector
|
GrantCommon Stock | 188 | $292.16 | $54,926.08 |
DisclosureSEC source: 0001179929-24-000111 · wk-form4_1719953752.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,977 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2024, was $292.16, which resulted in a grant of 188 shares. F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2024. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:55 UTC |
ROMNEY RONNADirector
|
GrantCommon Stock | 188 | $292.16 | $54,926.08 |
DisclosureSEC source: 0001179929-24-000110 · wk-form4_1719953707.xml · nonDerivative · entry 1 ROMNEY RONNA · CIK 0001206684 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trust Disclosed balance after: 17,133 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2024, was $292.16, which resulted in a grant of 188 shares. F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2024. F4 · ownership.nature: All shares held by Ronna Romney Revocable Trust. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:54 UTC |
Bacon DebraEVP, Medicaid
|
Tax withholdingCommon Stock | 184 | $292.16 | $53,757.44 |
DisclosureSEC source: 0001179929-24-000109 · wk-form4_1719953665.xml · nonDerivative · entry 2 Bacon Debra · CIK 0002010075 · EVP, Medicaid 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,505 F3 · price: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 531 shares on July 1, 2024. F4 · balance_after: The shares vest as follows: 1,231 shares on January 1, 2025; 1,249 shares on March 1, 2025; 530 shares on July 1, 2025; 1,003 shares on March 1, 2026; 529 shares on July 1, 2026; and 757 shares on March 1, 2027. The remaining shares are vested. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 20:54 UTC |
Bacon DebraEVP, Medicaid
|
GrantCommon Stock | 13 | $252.71 | $3,285.23 |
DisclosureSEC source: 0001179929-24-000109 · wk-form4_1719953665.xml · nonDerivative · entry 1 Bacon Debra · CIK 0002010075 · EVP, Medicaid 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,689 F1 · kind: The shares were acquired under the Molina Healthcare, Inc. 2019 Employee Stock Purchase Plan (the "ESPP"). F2 · price: In accordance with the ESPP provisions, the purchase price is 85% of the closing price of the Issuer's common stock on June 28, 2024 of $297.30 (which represents the lower market price of the Issuer's common stock as of (i) January 1, 2024, the first date of the ESPP offering period, and (ii) June 28, 2024, the last trading day of the offering period). Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 20:53 UTC |
WOYS JAMESChief Operating Officer
|
GrantCommon Stock | 69 | $252.71 | $17,436.99 |
DisclosureSEC source: 0001179929-24-000108 · wk-form4_1719953617.xml · nonDerivative · entry 1 WOYS JAMES · CIK 0001213947 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,682 F1 · kind: The shares were acquired under the Molina Healthcare, Inc. 2019 Employee Stock Purchase Plan (the "ESPP"). F2 · price: In accordance with the ESPP provisions, the purchase price is 85% of the closing price of the Issuer's common stock on June 28, 2024 of $297.30 (which represents the lower market price of the Issuer's common stock as of (i) January 1, 2024, the first date of the ESPP offering period, and (ii) June 28, 2024, the last trading day of the offering period). F3 · balance_after: The shares vest as follows: 4,643 shares on March 1, 2025; 3,254 shares on March 1, 2026; and 1,549 shares on March 1, 2027. The remaining shares are vested. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 20:52 UTC |
Barlow Jeff D.Chief Legal Officer
|
GrantCommon Stock | 69 | $252.71 | $17,436.99 |
DisclosureSEC source: 0001179929-24-000107 · wk-form4_1719953571.xml · nonDerivative · entry 1 Barlow Jeff D. · CIK 0001555603 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,488 F1 · kind: The shares were acquired under the Molina Healthcare, Inc. 2019 Employee Stock Purchase Plan (the "ESPP"). F2 · price: In accordance with the ESPP provisions, the purchase price is 85% of the closing price of the Issuer's common stock on June 28, 2024 of $297.30 (which represents the lower market price of the Issuer's common stock as of (i) January 1, 2024, the first date of the ESPP offering period, and (ii) June 28, 2024, the last trading day of the offering period). F3 · balance_after: The shares vest as follows: 3,738 shares on March 1, 2025; 2,563 shares on March 1, 2026; and 1,102 shares on March 1, 2027. The remaining shares are vested. Read SEC document |
| May 22, 2024 Filed May 24, 2024 21:34 UTC |
WOYS JAMESChief Operating Officer
|
SaleCommon Stock | 100 | $347.93 | $34,793.00 |
DisclosureSEC source: 0001179929-24-000095 · wk-form4_1716586439.xml · nonDerivative · entry 6 WOYS JAMES · CIK 0001213947 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,613 F1 · kind: The sale was made pursuant to Reporting Person's Rule 10b5-1 Trading Plan that was established on February 20, 2024. F7 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $347.92 to $347.93. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| May 22, 2024 Filed May 24, 2024 21:34 UTC |
WOYS JAMESChief Operating Officer
|
SaleCommon Stock | 350 | $347.08 | $121,478.00 |
DisclosureSEC source: 0001179929-24-000095 · wk-form4_1716586439.xml · nonDerivative · entry 5 WOYS JAMES · CIK 0001213947 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,713 F1 · kind: The sale was made pursuant to Reporting Person's Rule 10b5-1 Trading Plan that was established on February 20, 2024. F6 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $346.74 to $347.58. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| May 22, 2024 Filed May 24, 2024 21:34 UTC |
WOYS JAMESChief Operating Officer
|
SaleCommon Stock | 1,743 | $346.07 | $603,200.01 |
DisclosureSEC source: 0001179929-24-000095 · wk-form4_1716586439.xml · nonDerivative · entry 4 WOYS JAMES · CIK 0001213947 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,063 F1 · kind: The sale was made pursuant to Reporting Person's Rule 10b5-1 Trading Plan that was established on February 20, 2024. F5 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $345.70 to $346.70. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| May 22, 2024 Filed May 24, 2024 21:34 UTC |
WOYS JAMESChief Operating Officer
|
SaleCommon Stock | 5,607 | $345.19 | $1,935,480.33 |
DisclosureSEC source: 0001179929-24-000095 · wk-form4_1716586439.xml · nonDerivative · entry 3 WOYS JAMES · CIK 0001213947 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 55,806 F1 · kind: The sale was made pursuant to Reporting Person's Rule 10b5-1 Trading Plan that was established on February 20, 2024. F4 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $344.69 to $345.68. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| May 22, 2024 Filed May 24, 2024 21:34 UTC |
WOYS JAMESChief Operating Officer
|
SaleCommon Stock | 1,450 | $344.32 | $499,264.00 |
DisclosureSEC source: 0001179929-24-000095 · wk-form4_1716586439.xml · nonDerivative · entry 2 WOYS JAMES · CIK 0001213947 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 61,413 F1 · kind: The sale was made pursuant to Reporting Person's Rule 10b5-1 Trading Plan that was established on February 20, 2024. F3 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $343.64 to $344.62. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| May 22, 2024 Filed May 24, 2024 21:34 UTC |
WOYS JAMESChief Operating Officer
|
SaleCommon Stock | 750 | $343.02 | $257,265.00 |
DisclosureSEC source: 0001179929-24-000095 · wk-form4_1716586439.xml · nonDerivative · entry 1 WOYS JAMES · CIK 0001213947 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 62,863 F1 · kind: The sale was made pursuant to Reporting Person's Rule 10b5-1 Trading Plan that was established on February 20, 2024. F2 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $342.61 to $343.46. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| May 21, 2024 Filed May 22, 2024 20:59 UTC |
ROMNEY RONNADirector
|
SaleCommon Stock | 250 | $343.27 | $85,817.50 |
DisclosureSEC source: 0001179929-24-000093 · wk-form4_1716411558.xml · nonDerivative · entry 1 ROMNEY RONNA · CIK 0001206684 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trust Disclosed balance after: 16,945 F1 · price: Represents the actual selling price per share of all 250 shares. F2 · ownership.nature: All shares held by Ronna Romney Revocable Trust. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 20:52 UTC |
BRASIER BARBARA LDirector
|
GrantCommon Stock | 136 | $404.20 | $54,971.20 |
DisclosureSEC source: 0001179929-24-000076 · wk-form4_1712091119.xml · nonDerivative · entry 1 BRASIER BARBARA L · CIK 0001169490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,688 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2024 was $404.20, which resulted in a grant of 136 shares. F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2024. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 21:01 UTC |
Lockhart Stephen HDirector
|
GrantCommon Stock | 136 | $404.20 | $54,971.20 |
DisclosureSEC source: 0001179929-24-000083 · wk-form4_1712091677.xml · nonDerivative · entry 1 Lockhart Stephen H · CIK 0001856013 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,254 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2024, was $404.20, which resulted in a grant of 136 shares. F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2024. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 21:00 UTC |
ZORETIC RICHARD CDirector
|
GrantCommon Stock | 136 | $404.20 | $54,971.20 |
DisclosureSEC source: 0001179929-24-000082 · wk-form4_1712091626.xml · nonDerivative · entry 1 ZORETIC RICHARD C · CIK 0001263714 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trust Disclosed balance after: 6,459 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2024, was $404.20, which resulted in a grant of 136 shares. F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2024. F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 20:59 UTC |
Schapiro Richard MDirector
|
GrantCommon Stock | 136 | $404.20 | $54,971.20 |
DisclosureSEC source: 0001179929-24-000081 · wk-form4_1712091533.xml · nonDerivative · entry 1 Schapiro Richard M · CIK 0001649773 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,343 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2024, was $404.20, which resulted in a grant of 136 shares. F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2024. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 20:57 UTC |
WOLF DALE BDirector
|
GrantCommon Stock | 136 | $404.20 | $54,971.20 |
DisclosureSEC source: 0001179929-24-000080 · wk-form4_1712091409.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,003 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2024, was $404.20, which resulted in a grant of 136 shares. F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2024. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 20:55 UTC |
ORLANDO STEVEN JDirector
|
GrantCommon Stock | 136 | $404.20 | $54,971.20 |
DisclosureSEC source: 0001179929-24-000079 · wk-form4_1712091326.xml · nonDerivative · entry 1 ORLANDO STEVEN J · CIK 0001211493 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trust Disclosed balance after: 18,837 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2024, was $404.20, which resulted in a grant of 136 shares. F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2024. F4 · ownership.nature: Shares are held by Orlando Family Trust. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 20:54 UTC |
ROMNEY RONNADirector
|
GrantCommon Stock | 136 | $404.20 | $54,971.20 |
DisclosureSEC source: 0001179929-24-000078 · wk-form4_1712091252.xml · nonDerivative · entry 1 ROMNEY RONNA · CIK 0001206684 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by trust Disclosed balance after: 17,195 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2024, was $404.20, which resulted in a grant of 136 shares. F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2024. F4 · ownership.nature: All shares held by Ronna Romney Revocable Trust. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 20:53 UTC |
COOPERMAN DANIELDirector
|
GrantCommon Stock | 136 | $404.20 | $54,971.20 |
DisclosureSEC source: 0001179929-24-000077 · wk-form4_1712091174.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,789 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2024, was $404.20, which resulted in a grant of 136 shares. F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:41 UTC |
Barlow Jeff D.Chief Legal Officer
|
GrantCommon Stock | 3,306 | $387.21 | $1,280,116.26 |
DisclosureSEC source: 0001179929-24-000058 · wk-form4_1709689276.xml · nonDerivative · entry 4 Barlow Jeff D. · CIK 0001555603 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,419 F5 · shares: Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024. F6 · balance_after: The shares shall vest as follows: The 3,306 newly granted shares shall vest in one-third on each of March 1, 2025, March 1, 2026, and March 1, 2027. Additional shares shall vest as follows: 2,636 shares shall vest on March 1, 2025; 1,461 shares shall vest on March 1, 2026. The shares total includes an additional five shares to correct a clerical error. The remaining shares are vested. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:41 UTC |
Barlow Jeff D.Chief Legal Officer
|
Tax withholdingCommon Stock | 2,205 | $387.21 | $853,798.05 |
DisclosureSEC source: 0001179929-24-000058 · wk-form4_1709689276.xml · nonDerivative · entry 3 Barlow Jeff D. · CIK 0001555603 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,113 F4 · shares: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 4,137 shares on March 1, 2024. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:41 UTC |
Barlow Jeff D.Chief Legal Officer
|
Tax withholdingCommon Stock | 6,133 | $387.21 | $2,374,758.93 |
DisclosureSEC source: 0001179929-24-000058 · wk-form4_1709689276.xml · nonDerivative · entry 2 Barlow Jeff D. · CIK 0001555603 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,318 F3 · shares: The shares were applied to payment of withholding taxes in connection with vesting of the above-mentioned performance stock units. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:41 UTC |
Barlow Jeff D.Chief Legal Officer
|
GrantCommon Stock | 11,473 | $387.21 | $4,442,460.33 |
DisclosureSEC source: 0001179929-24-000058 · wk-form4_1709689276.xml · nonDerivative · entry 1 Barlow Jeff D. · CIK 0001555603 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,451 F1 · shares: Shares issued in settlement of performance stock units granted on March 1, 2021, which vested at the 170% achievement level based on the Company's averaged achievement of adjusted net income per share in the three fiscal years of 2021, 2022, and 2023. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:40 UTC |
WOYS JAMESChief Operating Officer
|
GrantCommon Stock | 4,649 | $387.21 | $1,800,139.29 |
DisclosureSEC source: 0001179929-24-000057 · wk-form4_1709689226.xml · nonDerivative · entry 4 WOYS JAMES · CIK 0001213947 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,613 F5 · shares: Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024. F6 · balance_after: The shares shall vest as follows: The 4,649 newly granted shares shall vest in one-third on each of March 1, 2025, March 1, 2026, and March 1, 2027. Additional shares shall vest as follows: 3,093 shares shall vest on March 1, 2025; and 1,704 shares shall vest on March 1, 2026. The remaining shares are vested. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:40 UTC |
WOYS JAMESChief Operating Officer
|
Tax withholdingCommon Stock | 1,423 | $387.21 | $550,999.83 |
DisclosureSEC source: 0001179929-24-000057 · wk-form4_1709689226.xml · nonDerivative · entry 3 WOYS JAMES · CIK 0001213947 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,964 F4 · shares: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 4,594 shares on March 1, 2024. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:40 UTC |
WOYS JAMESChief Operating Officer
|
Tax withholdingCommon Stock | 4,515 | $387.21 | $1,748,253.15 |
DisclosureSEC source: 0001179929-24-000057 · wk-form4_1709689226.xml · nonDerivative · entry 2 WOYS JAMES · CIK 0001213947 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,387 F3 · shares: Shares were applied to payment of withholding taxes in connection with vesting of the above-mentioned performance stock units. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:40 UTC |
WOYS JAMESChief Operating Officer
|
GrantCommon Stock | 11,473 | $387.21 | $4,442,460.33 |
DisclosureSEC source: 0001179929-24-000057 · wk-form4_1709689226.xml · nonDerivative · entry 1 WOYS JAMES · CIK 0001213947 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,902 F1 · shares: Shares issued in settlement of performance stock units granted on March 1, 2021, which vested at the 170% achievement level based on the Company's averaged achievement of adjusted net income per share in the three fiscal years of 2021, 2022, and 2023. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:39 UTC |
Bacon DebraEVP, Medicaid
|
Tax withholdingCommon Stock | 170 | $387.21 | $65,825.70 |
DisclosureSEC source: 0001179929-24-000056 · wk-form4_1709689176.xml · nonDerivative · entry 2 Bacon Debra · CIK 0002010075 · EVP, Medicaid 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,676 F3 · kind: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 491 shares on March 1, 2024. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024. F4 · balance_after: The shares shall vest as follows: The 2,273 newly granted shares shall vest in one-third increments on each of March 1, 2025, March 1, 2026, and March 1, 2027. Additional shares shall vest as follows: 1, 231 shares shall vest on January 1, 2025; 491 shares shall vest on March 1, 2025; 245 shares shall vest on March 1, 2026; 531 shares shall vest on July 1, 2024; 530 shares shall vest on July 1, 2025; and 529 shares shall vest on July 1, 2026. The remainder of the shares are vested. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:39 UTC |
Bacon DebraEVP, Medicaid
|
GrantCommon Stock | 2,273 | $387.21 | $880,128.33 |
DisclosureSEC source: 0001179929-24-000056 · wk-form4_1709689176.xml · nonDerivative · entry 1 Bacon Debra · CIK 0002010075 · EVP, Medicaid 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,846 F1 · kind: Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:39 UTC |
HEBERT MAURICEChief Accounting Officer
|
GrantCommon Stock | 258 | $387.21 | $99,900.18 |
DisclosureSEC source: 0001179929-24-000055 · wk-form4_1709689139.xml · nonDerivative · entry 5 HEBERT MAURICE · CIK 0001267043 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,866 F5 · shares: Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024. F6 · balance_after: The shares shall vest as follows: The 774 newly granted shares shall vest in one-third on each of March 1, 2025, March 1, 2026, and March 1, 2027. Additional shares shall vest as follows: 643 shares shall vest on March 1, 2025; and 243 shares shall vest on March 1, 2026. The remaining shares are vested. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:39 UTC |
HEBERT MAURICEChief Accounting Officer
|
GrantCommon Stock | 516 | $387.12 | $199,753.92 |
DisclosureSEC source: 0001179929-24-000055 · wk-form4_1709689139.xml · nonDerivative · entry 4 HEBERT MAURICE · CIK 0001267043 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,608 F5 · shares: Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:39 UTC |
HEBERT MAURICEChief Accounting Officer
|
Tax withholdingCommon Stock | 516 | $387.21 | $199,800.36 |
DisclosureSEC source: 0001179929-24-000055 · wk-form4_1709689139.xml · nonDerivative · entry 3 HEBERT MAURICE · CIK 0001267043 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,092 F4 · shares: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 1,276 shares on March 1, 2024. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:39 UTC |
HEBERT MAURICEChief Accounting Officer
|
Tax withholdingCommon Stock | 450 | $387.21 | $174,244.50 |
DisclosureSEC source: 0001179929-24-000055 · wk-form4_1709689139.xml · nonDerivative · entry 2 HEBERT MAURICE · CIK 0001267043 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,608 F3 · shares: The shares were applied to payment of withholding taxes in connection with vesting of the above-mentioned performance stock units. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:39 UTC |
HEBERT MAURICEChief Accounting Officer
|
GrantCommon Stock | 1,530 | $387.21 | $592,431.30 |
DisclosureSEC source: 0001179929-24-000055 · wk-form4_1709689139.xml · nonDerivative · entry 1 HEBERT MAURICE · CIK 0001267043 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,058 F1 · shares: Shares issued in settlement of performance stock units granted on March 1, 2021, which vested at the 170% achievement level based on the Company's averaged achievement of adjusted net income per share in the three fiscal years of 2021, 2022, and 2023. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:38 UTC |
Keim Mark LowellChief Financial Officer
|
GrantCommon Stock | 5,165 | $387.12 | $1,999,474.80 |
DisclosureSEC source: 0001179929-24-000054 · wk-form4_1709689081.xml · nonDerivative · entry 4 Keim Mark Lowell · CIK 0001690677 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,594 F5 · shares: Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024. F6 · balance_after: The shares shall vest as follows: The 5,165 newly granted shares shall vest in one-third increments on each of March 1, 2025, March 1, 2026, and March 1, 2027. The additional shares shall vest as follows: 3,551 shares shall vest on March 1, 2025; and 1,948 shares shall vest on March 1, 2026. The remainder of the shares are vested. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:38 UTC |
Keim Mark LowellChief Financial Officer
|
Tax withholdingCommon Stock | 2,507 | $387.21 | $970,735.47 |
DisclosureSEC source: 0001179929-24-000054 · wk-form4_1709689081.xml · nonDerivative · entry 3 Keim Mark Lowell · CIK 0001690677 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,429 F4 · shares: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 5,651 shares on March 1, 2024. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:38 UTC |
Keim Mark LowellChief Financial Officer
|
Tax withholdingCommon Stock | 7,658 | $387.21 | $2,965,254.18 |
DisclosureSEC source: 0001179929-24-000054 · wk-form4_1709689081.xml · nonDerivative · entry 2 Keim Mark Lowell · CIK 0001690677 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,936 F3 · shares: Shares were applied to payment of withholding taxes in connection with vesting of the above-mentioned performance stock units. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:38 UTC |
Keim Mark LowellChief Financial Officer
|
GrantCommon Stock | 16,063 | $387.21 | $6,219,754.23 |
DisclosureSEC source: 0001179929-24-000054 · wk-form4_1709689081.xml · nonDerivative · entry 1 Keim Mark Lowell · CIK 0001690677 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,594 F1 · shares: Shares issued in settlement of performance stock units granted on March 1, 2021, which vested at the 170% achievement level based on the Company's averaged achievement of adjusted net income per share in the three fiscal years of 2021, 2022, and 2023. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:37 UTC |
Zubretsky Joseph MDirector · President & CEO
|
GrantCommon Stock | 16,735 | $387.21 | $6,479,959.35 |
DisclosureSEC source: 0001179929-24-000052 · wk-form4_1709689020.xml · nonDerivative · entry 4 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 349,952 F5 · shares: Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024. F6 · balance_after: The shares shall vest as follows: The 16,735 newly granted shares shall vest in one-third on each of March 1, 2025, March 1, 2026, and March 1, 2027. Additional shares shall vest as follows: 13,960 shares shall vest on March 1, 2025; and 7,548 shares shall vest on March 1, 2026. The remaining shares are vested. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:37 UTC |
Zubretsky Joseph MDirector · President & CEO
|
Tax withholdingCommon Stock | 27,374 | $387.21 | $10,599,486.54 |
DisclosureSEC source: 0001179929-24-000052 · wk-form4_1709689020.xml · nonDerivative · entry 3 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 333,217 F4 · shares: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 22,960 shares on March 1, 2024. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:37 UTC |
Zubretsky Joseph MDirector · President & CEO
|
Tax withholdingCommon Stock | 32,069 | $387.21 | $12,417,437.49 |
DisclosureSEC source: 0001179929-24-000052 · wk-form4_1709689020.xml · nonDerivative · entry 2 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 360,591 F3 · shares: The shares were applied to payment of withholding taxes in connection with vesting of the above-mentioned performance stock units. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:37 UTC |
Zubretsky Joseph MDirector · President & CEO
|
GrantCommon Stock | 68,844 | $387.21 | $26,657,085.24 |
DisclosureSEC source: 0001179929-24-000052 · wk-form4_1709689020.xml · nonDerivative · entry 1 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 392,660 F1 · shares: Shares issued in settlement of performance stock units granted on March 1, 2021, which vested at the 170% achievement level based on the Company's averaged achievement of adjusted net income per share in the three fiscal years of 2021, 2022, and 2023. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024. Read SEC document |
| February 20, 2024 Filed Feb 20, 2024 21:56 UTC |
Schapiro Richard MDirector
|
SaleCommon Stock | 20 | $403.06 | $8,061.20 |
DisclosureSEC source: 0001179929-24-000045 · wk-form4_1708466157.xml · nonDerivative · entry 4 Schapiro Richard M · CIK 0001649773 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,207 F4 · price: Represents the selling price per share of all 20 shares. Read SEC document |
| February 20, 2024 Filed Feb 20, 2024 21:56 UTC |
Schapiro Richard MDirector
|
SaleCommon Stock | 180 | $402.03 | $72,365.40 |
DisclosureSEC source: 0001179929-24-000045 · wk-form4_1708466157.xml · nonDerivative · entry 3 Schapiro Richard M · CIK 0001649773 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,227 F3 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $401.985 to $402.100. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| February 20, 2024 Filed Feb 20, 2024 21:56 UTC |
Schapiro Richard MDirector
|
SaleCommon Stock | 475 | $401.23 | $190,584.25 |
DisclosureSEC source: 0001179929-24-000045 · wk-form4_1708466157.xml · nonDerivative · entry 2 Schapiro Richard M · CIK 0001649773 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,407 F2 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $400.77 to $401.39. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| February 20, 2024 Filed Feb 20, 2024 21:56 UTC |
Schapiro Richard MDirector
|
SaleCommon Stock | 325 | $400.12 | $130,039.00 |
DisclosureSEC source: 0001179929-24-000045 · wk-form4_1708466157.xml · nonDerivative · entry 1 Schapiro Richard M · CIK 0001649773 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,882 F1 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $399.43 to $400.36. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.